10.1038/nature25486 [DOI] [PMC free article] [PubMed] [Google Scholar] Woodcock J, LaVange LM (2017) Master protocols to study multiple therapies, multiple diseases, or both
The Potential ROI for Covering GLP-1s, Workspan Daily Plus+ article Beyond the Rx: Maximizing GLP-1 Value Through Employee Support, Workspan Daily Plus+ article A Prescription for Rising Drug Costs, Workspan Magazine article For Everyone What Does the Data Show on GLP-1 Prescribe Rates, Coverage, Costs
Weight Loss Has Never Been Easier Forget the insurance providers and soaring monthly costs
GLP-1 Therapy Shifts from Molecule to Delivery The GLP-1 Race Is No Longer About the Molecule Its About Delivery On January 12, 2026, Chinas CDE approved Shiling Pharmas Semaglutide Nasal Spray for clinical trials in long-term weight managementmarking the worlds first mucosal GLP-1 therapy (Class 2.2 innovation)
Research shows it may also help protect nerve cells, improve hair growth by stimulating follicle activity, and even support organ repair
Correlation between HHV-6 reactivation and multiple sclerosis disease activity
